Impact of SARS-CoV-2 variants infection on mid- and long-term outcomes in Puerto Ricans with systemic lupus erythematosus: Two-year follow-up

Abstract

Keywords

Systemic lupus erythematosus SARS-CoV-2 COVID-19 Clinical outcomes Puerto Rico

Get full access to this article

View all access options for this article.

References

Rojas

Herrán

Ramírez-Santana

, et al. Molecular mimicry and autoimmunity in the time of COVID-19. J Autoimmun 2023; 139: 103070.

Serrano-Arroyo

González-Meléndez

Ríos-Rivera

, et al. Impact of SARS-CoV-2 pre-delta/delta and omicron variants on clinical outcomes in a systemic lupus erythematosus cohort from Puerto Rico. Lupus 2025; 34(4): 415–424.

Hejazian

Farnood

, et al. Dysregulation of immunity in COVID-19 and SLE. Inflammopharmacology 2022; 30(5): 1517–1531.

Solé

Domingo

Vidal

, et al. Humoral and cellular response in convalescent COVID-19 lupus patients. Sci Rep 2022; 12(1): 13787.

Schioppo

Argolini

Sciascia

, et al. Clinical and peculiar immunological manifestations of SARS-CoV-2 infection in systemic lupus erythematosus patients. Rheumatology 2022; 61: 1928–1935.

Mok

Cheung

CCL

Chan

, et al. Effect of SARS-CoV-2 infection on disease flares in patients with systemic lupus erythematosus: a case–control study. Rheumatology 2024; 63(12): 3390–3396.